Venus Concept Inc. (VERO)
Market Cap | 4.18M |
Revenue (ttm) | 73.30M |
Net Income (ttm) | -37.39M |
Shares Out | 6.36M |
EPS (ttm) | -6.68 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 38,303 |
Open | 0.691 |
Previous Close | 0.719 |
Day's Range | 0.650 - 0.704 |
52-Week Range | 0.460 - 2.440 |
Beta | 0.53 |
Analysts | Hold |
Price Target | n/a |
Earnings Date | Aug 12, 2024 |
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF ... [Read more]
Financial Performance
In 2023, Venus Concept's revenue was $76.35 million, a decrease of -23.26% compared to the previous year's $99.50 million. Losses were -$37.25 million, -14.76% less than in 2022.
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/y/t/press20-2499422.jpg)
Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of it...
![](https://cdn.snapi.dev/images/v1/h/f/press7-2481679.jpg)
Venus Concept Announces Exclusive Strategic Supply Arrangement with Skin Laundry
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has entered a new...
![](https://cdn.snapi.dev/images/v1/x/c/press10-2465771.jpg)
Venus Concept Regains Compliance with Nasdaq's Minimum Equity Requirement
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was no...
![](https://cdn.snapi.dev/images/v1/8/k/press8-2458673.jpg)
Venus Concept Announces Approval for Venus Versa Pro in Canada
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a me...
![](https://cdn.snapi.dev/images/v1/t/3/press6-2449534.jpg)
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
Substantial Reduction of Existing Debt by Madryn Asset Management to Support Restructuring Efforts and Compliance with NASDAQ Listing Requirements Substantial Reduction of Existing Debt by Madryn Asse...
![](https://cdn.snapi.dev/images/v1/g/z/press16-2431612.jpg)
Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...
![](https://cdn.snapi.dev/images/v1/k/5/conf14-2371161.jpg)
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fi...
![](https://cdn.snapi.dev/images/v1/3/m/press18-2360665.jpg)
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received app...
![](https://cdn.snapi.dev/images/v1/e/y/press16-2353918.jpg)
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic ...
![](https://cdn.snapi.dev/images/v1/a/r/press16-2349397.jpg)
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
TORONTO, April 01, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the thre...
![](https://cdn.snapi.dev/images/v1/u/t/press15-2339463.jpg)
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the “Nasdaq...
![](https://cdn.snapi.dev/images/v1/k/x/press4-2320911.jpg)
Venus Concept Launches “NEXThetics” Program
New Venus AI Event Series Focused on Enhancing Customer Education and Training New Venus AI Event Series Focused on Enhancing Customer Education and Training
![](https://cdn.snapi.dev/images/v1/5/y/press8-2296868.jpg)
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has closed its pr...
![](https://cdn.snapi.dev/images/v1/v/v/press10-2290835.jpg)
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into ...
![](https://cdn.snapi.dev/images/v1/4/p/press15-2288198.jpg)
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received the ...
![](https://cdn.snapi.dev/images/v1/q/3/conf20-2283186.jpg)
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and f...
![](https://cdn.snapi.dev/images/v1/g/r/press13-2242038.jpg)
Venus Concept Inc. Announces Review of Strategic Alternatives
TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that its Board of Directo...
![](https://cdn.snapi.dev/images/v1/t/a/press19-2236023.jpg)
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
Sale of convertible notes provides additional financial flexibility and support for the Company's path to cash flow breakeven Sale of convertible notes provides additional financial flexibility and su...
![](https://cdn.snapi.dev/images/v1/4/t/press5-2232213.jpg)
Venus Concept Launches Venus Prime
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of Venus Prime...
![](https://cdn.snapi.dev/images/v1/q/1/press6-2199795.jpg)
Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced the expansion of its internatio...
![](https://cdn.snapi.dev/images/v1/a/x/press10-2157934.jpg)
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
![](https://cdn.snapi.dev/images/v1/r/r/press11-2132520.jpg)
Venus Concept Launches Venus Versa Pro, its new multi-application platform for face and body treatments
TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the commercial launch of ...
![](https://cdn.snapi.dev/images/v1/h/g/press16-2106219.jpg)
Venus Concept Launches New “Venus Aesthetic Intelligence” Branding and Updated “Venus.ai” Website to Reflect New Vision for the Company
TORONTO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today a company-wide rebranding...
![](https://cdn.snapi.dev/images/v1/i/6/press15-2100387.jpg)
Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the promotion of Dr. Hema...
![](https://cdn.snapi.dev/images/v1/7/l/conf11-2095717.jpg)
Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023
TORONTO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fis...